Application of the linear-quadratic model to myelotoxicity associated with radioimmunotherapy

European Journal of Nuclear Medicine

Volumn 23, Issue 8, 1996, Pages 953-957

  Wilder, Richard B ^a,d   DeNardo, Gerald L ^a   Sheri, Sui ^a   Fowler, John F ^b   Wessels, Barry W ^c   DeNardo, Sally J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Linear quadratic model; Radioimmunotherapy

Indexed keywords

MONOCLONAL ANTIBODY I 131;

ARTICLE; B CELL LYMPHOMA; BONE MARROW TOXICITY; CELL PROLIFERATION; CLINICAL ARTICLE; GRANULOCYTE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; RADIATION DOSE; RADIOIMMUNOTHERAPY; STEM CELL; THROMBOCYTE COUNT; TIME;

EID: 0029773655     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01084370     Document Type: Article

References (23)

1. 131I-Lym-1 as a model. Cancer 1994; 73: 1038-1048.
2. Dillman LT, Von Der Lage FC. Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation. New York: Society of Nuclear Medicine, 1975.
3. Snyder WS, Ford MR, Warner GG, Watson SB. "S" absorbed dose per unit cumulated activity for selected radionuclides and organs. New York: Society of Nuclear Medicine, 1975.
4. Loevinger R, Berman M. MIRD Pamphlet No. 1 revised. New York: Society of Nuclear Medicine, 1976.
5. Epstein AL, Marder RJ, Winter JN, Stathopoulos E, Chen F-M, Parker JW, Taylor CR. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human-B-Lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential. Cancer Res 1987; 47: 830-840.
6. Siegel JA, Wessels BW, Watson EE, Stabin MG, Vriesendorp HM, Bradley EW, Badger CC, Brill AB, Kwok CS, Stickney DR, Eckerman KF, Fischer DR, Buchsbaum DJ, Order SE. Bone marrow dosimetry and toxicity for radioimmunotherapy. Antibody Immunoconj Radiopharm 1990; 3: 213-233.
7. 131I-Lym-1 in patients with B-cell malignancies. Nucl Med Commun 1993; 14: 587-595.
8. DeNardo SJ, Macey DJ, DeNardo GL. A direct approach for determining marrow radiation from MoAb therapy. In: DeNardo GL, ed. Biology of radionuclide therapy. Washington, D.C.: American College of Nuclear Physicians, Publications Department; 1989: 110-124.
9. Macey DJ, DeNardo SJ, DeNardo GL, DeNardo DA, Shen S. Estimation of radiation absorbed doses to the red marrow in radioimmunotherapy. Clin Nucl Med 1995; 20: 117-125.
10. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989; 62: 679-694.
11. Dale RG. Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model. Br J Radiol 1989; 62: 241-244.
12. Schofield R. Assessment of cytotoxic injury to bone marrow. Br J Cancer 1986; 53: 115-125.
13. 131I Lym-1 monoclonal antibodies. Int J Cancer 1988; Suppl 3: 96-101.
14. 131I-Lym-1 radioimmunotherapy. Antibody Immunoconj Radiopharm 1995; 8: 227-239.
15. O'Donoghue JA. Isoeffect relationships for fractionated biologically targeted radiotherapy. Radiother Oncol 1990; 19: 257-265.
16. Brodsky A. Biological and mathematical information. CRC handbook of radiation measurements and protection. section A II. Florida: CRC Press; 1982: 148-150.
17. Hall EJ. Radiobiology for the radiologist. Philadelphia: J.B. Lippincott, 1994.
18. Hendry JH. The cellular basis of long-term marrow injury after irradiation. Radiother Oncol 1985; 3: 331-338.
19. Kimler BF, Park CH, Yakar D, Mies RM. Lack of recovery from radiation-induced sublethal damage in human haematopoietic cells. Br J Cancer 1984; 49: 221-225.
20. Thames HD, Hendry JH. Fractionation in radiotherapy. New York: Taylor and Francis, 1987.
21. Howell RW, Goddu SM, Rao DV. Application of the linearquadratic model to radioimmunotherapy. J Nucl Med 1994; 35: 1861-1869.
22. Fowler JF. Radiobiological aspects of low dose rates in radioimmunotherapy. Int J Radiat Oncol Biol Phys 1990; 18: 1261-1269.
23. Jonsson BA, Strand SE, Larsson BS. A quantitative autoradiographic study of the heterogeneous activity distribution of different indium-111-labeled radiopharmaceuticals in rat tissues. J Nucl Med 1992; 33: 1825-1832.